Categories: News

Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

– Company to host conference call and webcast on March 13, 2024, at 3pm CET/10am US EST

SCHLIEREN (ZURICH), SWITZERLAND / ACCESSWIRE / March 8, 2024 / Kuros Biosciences (“Kuros” or “the Company”), a leader in next-generation bone graft technologies, today announced that it will report its full-year financial results and provide a corporate update on its business on March 13, 2024. Following the announcement, the company will host a video conference call at 3pm CET/10am US EST to discuss the results.

To register for the video call, click here.

For further information, please contact:

Kuros Biosciences AG
Daniel Geiger
Chief Financial Officer
t: +41 44 733 47 47
e: daniel.geiger@kurosbio.com
LifeSci Advisors
Sandya von der Weid
Investors
t: +41 78 680 0538
e: svonderweid@lifesciadvisors.com

About Kuros Biosciences

Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic fusion technologies. With locations in the United States, Switzerland and the Netherlands, the company is listed on the SIX Swiss Exchange. The company’s first commercial product, MagnetOsTM, is a unique advanced bone graft that has already been used across three continents and in 25,000 fusion surgeries. For more information on the company, its products and pipeline, visit kurosbio.com.

SOURCE: Kuros Biosciences AG

View the original press release on accesswire.com

Staff

Recent Posts

ZLNA – Issuance of shares through set-off of option exercise fee

Oslo, 24 May 2025: Zelluna ASA (the "Company") refers to the resolution by the Company's…

16 hours ago

IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon…

16 hours ago

INDY 500 Stars Join Forces with ZERO Prostate Cancer to Put Veterans’ Health in the Spotlight at Memorial Day Weekend Races

INDIANAPOLIS, May 23, 2025 /PRNewswire/ -- This Memorial Day Weekend, the spotlight won't only be on…

1 day ago

Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering

IRVING, Texas, May 23, 2025 /PRNewswire/ -- Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI…

1 day ago